Cardiovascular outcomes and safety with linagliptin, a dipeptidyl peptidase-4 inhibitor, compared with the sulphonylurea glimepiride in older people with type 2 diabetes: A subgroup analysis of the randomized CAROLINA trial Article

Industry Collaboration International Collaboration

cited authors

  • Espeland, Mark A.; Pratley, Richard E.; Rosenstock, Julio; Kadowaki, Takashi; Seino, Yutaka; Zinman, Bernard; Marx, Nikolaus; McGuire, Darren K.; Andersen, Knut Robert; Mattheus, Michaela; Keller, Annett; Weber, Maria; Johansen, Odd Erik

authors

Publication Date

  • December 6, 2020

webpage

published in

category

keywords

  • 4 inhibitor
  • DPP‐
  • cardiovascular disease
  • clinical trial
  • hypoglycaemia
  • linagliptin
  • sulphonylureas

start page

  • 569

end page

  • 580

volume

  • 23

issue

  • 2